Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.43 +2.59 (+3.66%)
As of: Nov 10, 2026 · 2:18 PM EST

Tarsus Pharmaceuticals (TARS) Share-based Compensation (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted Share-based Compensation of $27.22 million for Q3 2026, up 122.3% from $12.24 million a year earlier and up 104.8% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Share-based Compensation (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Share-based Compensation at Tarsus Pharmaceuticals was $66.79 million, up 91.9% year-over-year; for FY2025, it came in at $41.72 million, up 50.0% from FY2024.

  • Annual Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 68.0% (FY2020 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' Share-based Compensation was $27.82 million in FY2024 (+40.3%), $19.83 million in FY2023 (+47.3%), $13.46 million in FY2022 (+59.2%) and $8.46 million in FY2021 (+171.4%).
  • The Q3 2026 figure stands as the highest quarterly Share-based Compensation in data going back to Q4 2019.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last 17 quarters, with growth averaging 60.7% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2022, with growth of 358.2%; the weakest was Q1 2022, with a decline of 51.3%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $13.29 million (Q2 2026), $11.97 million (Q1 2026) and $14.31 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 Tarsus Pharmaceuticals 3.35 Bn 2.41 Bn 180.68 Mn 27.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 27.22 Mn
Jun 30, 2026 13.29 Mn
Mar 31, 2026 11.97 Mn
Dec 31, 2025 14.31 Mn
Sep 30, 2025 12.24 Mn
Jun 30, 2025 8.23 Mn
Mar 31, 2025 6.93 Mn
Dec 31, 2024 7.40 Mn
Sep 30, 2024 7.42 Mn
Jun 30, 2024 7.48 Mn
Mar 31, 2024 5.52 Mn
Dec 31, 2023 5.48 Mn
Sep 30, 2023 5.25 Mn
Jun 30, 2023 5.19 Mn
Mar 31, 2023 3.91 Mn
Dec 31, 2022 3.67 Mn
Sep 30, 2022 3.58 Mn
Jun 30, 2022 3.53 Mn
Mar 31, 2022 2.67 Mn
Dec 31, 2021 2.18 Mn
API Access

Tarsus Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TARS&period=max&api_key=YOUR_API_KEY